Abstract
The tritium-labelled analogues of pimonidazole and RSU 1069 were injected into mice bearing the KHT murine sarcoma which has a hypoxic cell fraction of approximately 10%. The distribution of activity at 24 h was recorded using autoradiography and measurement of tissue activity. Autoradiographs with both drugs showed high activity in particular cells within tumour, eye (melanin-associated cells), eyelid (Meibomian gland), liver (centrilobular area), skin (sebaceous gland and melanin), stomach (squamous area), footpad, oesophagus, labial gland, Zymbal's gland, preputial gland, parotid gland (intralobular ducts) and airway epithelium. These tissues had previously been identified as sites of binding of misonidazole. The measurement of total tissue radioactivity showed significantly higher activity in liver, eyelid (Meibomian gland), oesophageal lining, kidney and labial gland than was found in the tumour.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cobb, L., Nolan, J. & Butler, S. Distribution of pimonidazole and RSU 1069 in tumour and normal tissues. Br J Cancer 62, 915–918 (1990). https://doi.org/10.1038/bjc.1990.408
Issue date:
DOI: https://doi.org/10.1038/bjc.1990.408
This article is cited by
-
Upregulation of Hypoxia-Inducible Factors in Normal and Psoriatic Skin
Journal of Investigative Dermatology (2007)
-
Oxygen Levels in Normal and Previously Irradiated Human Skin as Assessed by EF5 Binding
Journal of Investigative Dermatology (2006)
-
Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazole
Cancer Chemotherapy and Pharmacology (1993)


